The Latest
-
Science Corporation raises $400M to commercialize BCI device
The device, which Science has launched in Europe, is designed to restore the sight of people with some forms of vision loss.
-
Remedy Robotics raises $62M; Capstan’s mitral replacement robot progresses
Remedy plans a pivotal trial and has its sights on bringing to market a system for neurovascular intervention, while Capstan Medical performed the first U.S. transcatheter mitral valve replacement with its investigational robot.
-
White House pulls nomination for FDA nominee Overton
The sudden end of Heidi Overton’s candidacy likely ensures a Democrat-controlled Congress will choose the FDA’s next leader — but shouldn’t disrupt the agency, analysts say.
-
Medtronic’s Hugo robot gets expanded FDA clearance in general surgery
The specialties gaining authorization account for more than half of the soft tissue procedures performed annually in the U.S.
-
Galvanize raises $130M to advance pulsed electric field ablation
The Series D round will support commercialization of Galvanize’s soft-tissue ablation platform and development of a chronic bronchitis device.
-
Medtronic to buy Contego Medical for $380M
The deal is intended to expand Medtronic’s portfolio of carotid artery and peripheral vascular disease treatments.
-
Apple, OpenEvidence launch conversational health AI study and app
The tech juggernaut and clinical AI company will research what drives consumer trust and the quality of health AI responses, among other areas. Apple could use the findings to inform product development.
-
MiniMed gets FDA nod for tubeless insulin pump
MiniMed will go head to head with Tandem Diabetes Care as both companies debut their first tubeless pumps.
-
Tandem wins FDA clearance for tubeless automated insulin delivery system
The clearance tees up a 2027 launch of a product that analysts called Tandem’s “single most important commercial catalyst and growth driver.”
-
Olympus making strides on FDA quality concerns, CEO says
CEO Bob White said the endoscope manufacturer accelerated its remediation and quality improvement efforts to “provide the sustained evidence that the agency is expecting.”
-
FDA posts early alerts for 2 product removals
Intersurgical told customers to immediately stop using affected devices, while Arrow International instructed users to quarantine and return certain products.
-
Tandem recalls Mobi insulin pump, reports 230 adverse events
A problem with a false occlusion alarm could interrupt insulin delivery for users, according to an entry in the FDA’s recall database.
-
Bipartisan push possible to curb Trump tariffs
Three bills in Congress would significantly restrict presidential tariff power if they become law, and experts say there's appetite for change in trade policy.
-
Abbott’s defibrillation lead lands FDA approval and CE mark
The authorizations position Abbott to launch a purpose-built lead for left bundle branch area pacing in the U.S. and Europe.
-
J&J leads Francis Medical investment to fund prostate cancer device
With Johnson & Johnson’s support, Francis plans to take its water-vapor therapy device through the premarket approval process.
-
Oura makes bet on AI in healthcare with $625M Counsel Health buy
The planned acquisition comes as wearable firms push to up their healthcare offerings.
-
The image by Coolcaesar is licensed under CC BY-SA 4.0
Danaher’s Cepheid business to lay off 67 people in California
The job cuts at Danaher’s molecular diagnostics subsidiary will take place by the end of the year and affect mostly scientists and engineers, according to a state filing.
-
Virtuoso robot wins FDA nod for bladder tumor removal
Virtuoso Surgical’s robotic system can remove lesions in one piece in a minimally invasive procedure designed to improve cancer diagnosis and staging.
-
FDA seeks input on telesurgery, autonomous robotics
The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical devices with autonomous or remote teleoperation functions.
-
Getinge hires president of acute care therapies
Stacy Beske joins Getinge from Philips and will take over the role on Dec. 1.
-
Novocure denied FDA approval for metastatic cancer treatment
The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.
-
Labcorp completes $375M Millennium Health takeover
The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.
-
Natera promotes Solomon Moshkevich to CEO
The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for the role.
-
Top medtech conferences in 2027
From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.
Updated Nov. 6, 2026 -
Siemens Healthineers to rebrand and separate its IVD business
The company is rebranding the unit as Olyrian Diagnostics and plans to set it up as a standalone business by mid-2028.